Blood contact with artificial surfaces during BVAD support

被引:9
作者
Hasper, D
Hummel, M
Hetzer, R
Volk, HD
机构
[1] HUMBOLDT UNIV BERLIN,KLINIKUM CHARITE,INST MED IMMUNOL,DEPT MED IMMUNOL,D-10098 BERLIN,GERMANY
[2] GERMAN HEART INST,DEPT THORAC & CARDIOVASC SURG,BERLIN,GERMANY
关键词
biventricular assist device system; artificial surface; biocompatibility; cytokines;
D O I
10.1177/039139889601901006
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Persistently elevated levels of cytokines (IL-6, IL-8) during the course of mechanical circulatory support correlate well with fatal outcome. To determine the influence of blood/artificial surface interaction on the chronic inflammatory process, we studied the biocompatibility of silicone and polyurethane membranes in vitro. Cultures of isolated mononuclear cells or whole blood were incubated for 24 hours in tubes coated with silicone or polyurethane, both used in the construction of ventricular assist systems. Concentrations of several inflammatory mediators were measured in the supernatant. Our results can be summarized as follows: a) Monocytes were stimulated to release inflammatory cytokines like IL-8 and MIP-1a, particularly when silicone was involved; b) Both silicone and polyurethane stimulated thrombocytes thus resulting in the release of P-Selectin and PDGF-AB, although polyurethane was a stronger stimulus, c) Moderate complement activation was triggered by contact with either of the artificial surfaces. However, the prevention of most of these effects by coating the artificial surface with protein and the lack of correlation between in vitro data and serum levels of IL-6 and IL-8 during the course of circulatory support suggest that the persistence of inflammatory cytokines during BVAD support is not caused by blood/surface interaction.
引用
收藏
页码:590 / 596
页数:7
相关论文
共 18 条
[1]  
ASOKA H, 1993, NIPPON RINSHO, V51, P1677
[2]  
BRAUTBAR N, 1992, TOXICOL IND HLTH, V340, P510
[3]   INVITRO LEUKOCYTE ADHESION TO MODIFIED POLYURETHANE SURFACES .1. EFFECT OF IONIZABLE FUNCTIONAL-GROUPS [J].
BRUIL, A ;
TERLINGEN, JGA ;
BEUGELING, T ;
VANAKEN, WG ;
FEIJEN, J .
BIOMATERIALS, 1992, 13 (13) :915-923
[4]   RESPONSE OF SERUM INTERLEUKIN-6 IN PATIENTS UNDERGOING ELECTIVE SURGERY OF VARYING SEVERITY [J].
CRUICKSHANK, AM ;
FRASER, WD ;
BURNS, HJG ;
VANDAMME, J ;
SHENKIN, A .
CLINICAL SCIENCE, 1990, 79 (02) :161-165
[5]   RED-BLOOD-CELLS ARE A SINK FOR INTERLEUKIN-8, A LEUKOCYTE CHEMOTAXIN [J].
DARBONNE, WC ;
RICE, GC ;
MOHLER, MA ;
APPLE, T ;
HEBERT, CA ;
VALENTE, AJ ;
BAKER, JB .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (04) :1362-1369
[6]   INTERLEUKIN-8 RELEASE AND NEUTROPHIL DEGRANULATION AFTER PEDIATRIC CARDIOPULMONARY BYPASS [J].
FINN, A ;
NAIK, S ;
KLEIN, N ;
LEVINSKY, RJ ;
STROBEL, S ;
ELLIOTT, M .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 105 (02) :234-241
[7]   DIVALENT CATION-INDEPENDENT MACROPHAGE ADHESION INHIBITED BY MONOCLONAL-ANTIBODY TO MURINE SCAVENGER RECEPTOR [J].
FRASER, I ;
HUGHES, D ;
GORDON, S .
NATURE, 1993, 364 (6435) :343-345
[8]  
GAMBLE JR, 1989, P NATL ACAD SCI USA, V86, P7196
[9]  
Haeffner-Cavaillon N, 1988, Contrib Nephrol, V62, P86
[10]   INTERLEUKIN-6 AND INTERLEUKIN-8 CONCENTRATIONS AS PREDICTORS OF OUTCOME IN VENTRICULAR ASSIST DEVICE PATIENTS BEFORE HEART-TRANSPLANTATION [J].
HUMMEL, M ;
CZERLINSKI, S ;
FRIEDEL, N ;
LIEBENTHAL, C ;
HASPER, D ;
VONBAEHR, R ;
HETZER, R ;
VOLK, HD .
CRITICAL CARE MEDICINE, 1994, 22 (03) :448-454